Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-06-30T16:54:08.712Z Has data issue: false hasContentIssue false
  • English
  • Français

The Sustained Release of Galardin and Taxol from Gelatin Chondroitin Sulfate Coacervate Films

Published online by Cambridge University Press:  21 February 2011

Phillip F. Heller ,
G. Mark Jenkins ,
Linda Cheng ,
Kam Leong ,
Wen Shao ,
Jeffrey Brinker ,
Earl Hope ,
Cynthia Nater ,
Edward Lakatta  and
Jeffrey P. Froehlich
Phillip F. Heller
Affiliation:
Laboratory of Cardiovascular Sciences, Gerontology Research Center, Baltimore, Maryland 21214.
G. Mark Jenkins
Affiliation:
Laboratory of Cardiovascular Sciences, Gerontology Research Center, Baltimore, Maryland 21214.
Linda Cheng
Affiliation:
Laboratory of Cardiovascular Sciences, Gerontology Research Center, Baltimore, Maryland 21214.
Kam Leong
Affiliation:
Johns Hopkins University School of Medicine, Baltimore MD.
Wen Shao
Affiliation:
Johns Hopkins University School of Medicine, Baltimore MD.
Jeffrey Brinker
Affiliation:
Johns Hopkins University School of Medicine, Baltimore MD.
Earl Hope
Affiliation:
Johns Hopkins University School of Medicine, Baltimore MD.
Cynthia Nater
Affiliation:
Laboratory of Cardiovascular Sciences, Gerontology Research Center, Baltimore, Maryland 21214.
Edward Lakatta
Affiliation:
Laboratory of Cardiovascular Sciences, Gerontology Research Center, Baltimore, Maryland 21214.
Jeffrey P. Froehlich
Affiliation:
Laboratory of Cardiovascular Sciences, Gerontology Research Center, Baltimore, Maryland 21214.
Get access

Extract

Coronary artery atherosclerosis is the leading cause of death in the United States. Restenosis following percutaneous transluminal balloon angioplasty (PTCA) remains the limiting factor in the use of this treatment for coronary artery disease. Restenosis occurs in 30% of patients within 6 months. The restenotic lesion is a fibroproliferative response with resulting smooth muscle cell migration, proliferation and extracellular matrix production. Despite a decade of research there is no effective strategy for preventing restenosis in man.

Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 394: Symposium Z – Polymers in Medicine and Pharmacy , 1995 , 55
Copyright
Copyright © Materials Research Society 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Hermans, W.R., et al. J. Am. Coll. Cardiol. 20(4)767–80. (1992)Google Scholar
2. Fishman, D.L., et al. N. Engl. J. Med. 331(8):496–501 (1994).Google Scholar
3. Golumbek, P.T., et al. Cancer Research. 53(24)5841–5844 (1993).Google Scholar
4. Shao, W., and Leong, K.W. J. Biomaterials Sci. In press (1995).Google Scholar
5. Bendeck, M.P. et al. Circ. Res. 75(3):539–545 (1994).Google Scholar
6. Sollott, S., et al. J.C.I. 95:1869–1876 (1995).Google Scholar
7. Reichheimer, S., Tinnermeier, D.M., and Timmons, D.W. Analytical Chemistry 64:2323–2326 (1992).Google Scholar
8. Schwartz, R.S. et al. J.A.C.C. 19(2):267–274 (1992).Google Scholar